Y-mAbs Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2021.
  • Y-mAbs Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.44M, a 4.9% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.3M, a 19.8% increase from 2020.
  • Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $16.1M, a 246% increase from 2019.
  • Y-mAbs Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $4.66M, a 237% increase from 2018.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $19.3M +$3.2M +19.8% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-01
2020 $16.1M +$11.5M +246% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $4.66M +$3.28M +237% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.38M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.